Qigong and Executive Attention in Older Adults with Depressive Symptoms
Health Qigong Alleviates Depressive Symptoms in Older Adults Through Enhanced Executive Attention: a Randomized Controlled Trial
1 other identifier
interventional
200
0 countries
N/A
Brief Summary
The goal of this randomized controlled trial is to test whether executive attention unpacks the antidepressant effect of Baduanjin (a form of health qigong) in older adults. The main questions it aims to answer are:
- Is Baduanjin an effective treatment to enhance executive attention in older adults with depressive symptoms?
- Does Baduanjin work through enhanced executive attention to alleviate depressive symptoms in older adults? Researchers will compare Baduanjin with waitlist control. Participants will receive 12-week Baduanjin training (two sessions per week and 60 min per session).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2025
CompletedFirst Posted
Study publicly available on registry
February 28, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
March 3, 2025
February 1, 2025
2.8 years
February 24, 2025
February 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Executive attention
The Attention Network Test (ANT) will be used to assess executive attention. The ANT is a computer-based test based on a combination of Posner's cueing task and the Flanker task. Executive attention will be operationalized as the difference in reaction time (measured in ms) in congruent and incongruent trials.
Baseline and post-intervention (12 weeks after baseline)
Secondary Outcomes (5)
Depressive symptoms
Baseline and post-intervention (12 weeks after baseline)
Amplitude of N2 component
Baseline and post-intervention (12 weeks after baseline)
Amplitude of P3 component
Baseline and post-intervention (12 weeks after baseline)
Alerting
Baseline and post-intervention (12 weeks after baseline)
Orienting
Baseline and post-intervention (12 weeks after baseline)
Study Arms (2)
Baduanjin
EXPERIMENTALThis arm is for intervention group who will receive health qigong training.
Waitlist control
NO INTERVENTIONThe arm is for control group who will not receive any training.
Interventions
Participants will receive two 60-minute Baduanjin qigong training sessions every week under the instruction and supervision of qualified qigong instructors over 12 weeks (i.e., 24 sessions in total). Baduanjin qigong consists of eight forms of gentle movements, and it takes about 10 to 15 minutes to complete a full cycle. Participants will learn to practice each form gradually over the first 12 sessions. In the remaining 12 sessions, the participants will go through all the movements 2-3 times, with guided practice on rhythmic breathing and mind regulation (attention to body and breathing) to be performed in coordination with the movements. Instructions on each movement, voice-guide audios, and demonstration videos will be provided for participants' daily self-practice. They will be advised to practice Baduanjin for at least 10 minutes every day.
Eligibility Criteria
You may qualify if:
- have mild or severer levels of depressive symptoms, as indicated by Geriatric Depression Scale scores of 5 or above or Depression Anxiety and Stress Scale-21 depression subscale scores of 4 or above
- self-identified as physically stable and without life-threatening diseases
- be able to communicate in Cantonese or Mandarin.
You may not qualify if:
- (have a history of practicing or receiving training in any form of mind-body or regular exercises (including tai chi, yoga, and qigong or regular physical activity \> 3 times/week) during the month prior to recruitment
- have changed medications or the dose of medications prescribed for their health condition in the month prior to study enrollment
- have a severe cognitive or language impairment, as indicated by a score of less than 21 on the Montreal Cognitive Assessment
- receiving pharmacological treatment, electroconvulsive therapy, psychotherapy, or psychoeducation for any psychological or psychiatric condition upon the time of recruitment
- be unable to demonstrate satisfactory standing balance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
February 24, 2025
First Posted
February 28, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
October 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
March 3, 2025
Record last verified: 2025-02